<DOC>
	<DOCNO>NCT00005909</DOCNO>
	<brief_summary>The purpose study gain good understand alkaptonuria collect medical data patient may later participate new drug trial rare genetic disease . In alkaptonuria , pigment call homogentisic acid collect bone connective tissue , cause arthritis eventually bone fracture , also cause discoloration ear white eye . Some patient also develop kidney stone heart valve problem . Alkaptonuria study decade ; scientist expect gain comprehensive clinical information use current medical technique . Patients alkaptonuria least one month old may eligible study . Participants evaluate NIH Clinical Center 5 day every 2 3 year . They medical history , physical examination , routine blood urine test . Blood may also collect measure type collagen indicate new bone formation analyze DNA genetic study . 24-hour urine collection do measure organic acid homogentisic acid excretion , assess overall kidney function , evaluate bone metabolism . A total 89.5 ml ( 6 tablespoon ) blood drawn study adults 51 ml ( 3 tablespoon ) child . Patients also bone X-rays , kidney ultrasound , brain chest computerized tomography ( CT ) scan , magnetic resonance imaging ( MRI ) scan affected joint , electrocardiogram , echocardiogram , lung function test , hear test . Photographs face full body ( underwear ) take . Patients also consultation dentistry ophthalmology , physical therapy rehabilitation medicine arthritis management , cardiology heart valve evaluation . When appropriate , patient may also dermatology , pulmonology neurology consultation . The information study enable doctor well advise patient alkaptonuria disease treatment option . It also prepare way clinical study new drug block production homogentisic acid .</brief_summary>
	<brief_title>Study Alkaptonuria</brief_title>
	<detailed_description>Alkaptonuria rare autosomal recessive disorder homogentisic acid accumulate destroys connective tissue bone , create condition call ochronosis . Symptoms generally begin third fourth decade progress incapacitate spondylosis , arthropathy , fracture sixth eighth decade . Cardiac valve deterioration renal prostrate calculus also occur . Diagnosis make measurement gram quantity urinary homogentisic acid , turn black alkali treatment exposure oxygen . In body , homogentisic acid form characteristic blue color cartilage ear brown color sclera eye . The gene homogentisic acid oxidase isolated 1996 , score different mutation define . Only symptomatic treatment available . We propose investigate 200 alkaptonuric patient , particularly adult , 5-day admission , define disorder use current medical technique . We use expertise disease advise population term prognosis therapy . Mutation analysis correlation genotype phenotype , perform secondary goal . Finally , use protocol recruit patient protocol 05-HG-0076 . `` Long-term Clinical Trial Nitisinone Alkaptonuria . '' Nitisinone promising drug inhibits formation homogentisic acid . The present protocol include treatment nitisinone . Instead , examine patient , measure baseline excretion homogentisic acid repeat 24-hour urine , characterize sign symptom alkaptonuria different age . This protocol also serve `` mother '' protocol alkaptonuria study emanate .</detailed_description>
	<mesh_term>Alkaptonuria</mesh_term>
	<mesh_term>Ochronosis</mesh_term>
	<criteria>INCLUSION CRITERIA : All patient enter study carry diagnosis alkaptonuria , although confirm diagnosis admission . EXCLUSION CRITERIA : Patients exclude travel NIH due medical condition , less two year old , imminent danger death due , e.g. , cardiac involvement .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 7, 2016</verification_date>
	<keyword>Homogentisic Acid</keyword>
	<keyword>Ochronosis</keyword>
	<keyword>Inborn Error Metabolism</keyword>
	<keyword>Arthritis</keyword>
	<keyword>Enzyme Defect</keyword>
	<keyword>Alkaptonuria</keyword>
	<keyword>Homogentisic Acid Oxidase</keyword>
</DOC>